← Open Payments lookup

JAMES WEHMEIER: Open Payments

NPI 1992417059 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$269 in 11 payments from 7 companies in 2025. Trend: 2023 $649 · 2024 $895 · 2025 $269

Food & beverage: $269
CompanyPaymentsAmount
Axsome Therapeutics, Inc.1$78
ABBVIE INC.4$77
Novo Nordisk Inc2$33
LivaNova USA, Inc.1$28
GlaxoSmithKline, LLC.1$18
Merz Pharmaceuticals, LLC1$18
Lilly USA, LLC1$17

Products named: Symbravo, UBRELVY, QULIPTA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, SHINGRIX, Ozempic, Xeomin, JARDIANCE.

Industry payments across MO — which companies pay providers there.